SSB - Network of Cancer Research

Rucaparib (AG014699) is an Orally Active PARP-1/2/3 Inhibitor

Poly (ADP-ribose) polymerase (PARP), a family of proteins, is involved in various cellular processes such as DNA repair and programmed cell death. PARP presents in the cell nucleus. It consists…

Breast Cancer Pancreas Cancer Solid Tumors

Venadaparib (IDX-1197) is a Potent and Selective PARP Inhibitor

Louis Gilman July 2, 2021

PARP is an enzyme that involved in a number of cellular processes such as DNA repair, and programmed cell death. The PARP family comprises 17 members. They have all very…

Breast Cancer

Rucaparib (AG014699) is an Orally Active PARP-1/2/3 Inhibitor

Venadaparib (IDX-1197) is a Potent and Selective PARP Inhibitor

You Missed

BI 7446 is a STING Agonist for Immuno-oncology Research

JNJ-38877605 is an Orally Active c-Met Inhibitor for Solid Tumour Research

OATD-02 is an Orally Active Arginase 1/2 Inhibitor for Melanoma Research

INCB086550 is an Orally Active PD-L1 Inhibitor for Multiple Cancers Research